β-glucan antigenemia anticipates diagnosis of blood culture-negative intraabdominal candidiasis.
about
Invasive candidiasis as a cause of sepsis in the critically ill patientDiagnosis and management of invasive candidiasis in the ICU: an updated approach to an old enemyEmpiric/pre-emptive anti-Candida therapy in non-neutropenic ICU patientsCandida colonization index and subsequent infection in critically ill surgical patients: 20 years laterIntensive care medicine research agenda on invasive fungal infection in critically ill patients.Invasive candidiasis: from mycobiome to infection, therapy, and prevention.Recent developments in the surgical management of complex intra-abdominal infection.Two missense mutations, E123Q and K151E, identified in the ERG11 allele of an azole-resistant isolate of Candida kefyr recovered from a stem cell transplant patient for acute myeloid leukemia.Intra-abdominal Candida spp infection in acute abdomen in a quality assurance (QA)-certified academic setting.Invasive candidiasis in critical care setting, updated recommendations from "Invasive Fungal Infections-Clinical Forum", Iran.Empirical antifungal therapy with an echinocandin in critically-ill patients: prospective evaluation of a pragmatic Candida score-based strategy in one medical ICUClinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.Relationship of fluconazole prophylaxis with fungal microbiology in hospitalized intra-abdominal surgery patients: a descriptive cohort study.Management of invasive candidiasis in nonneutropenic ICU patients.Can yeast isolation be predicted in complicated secondary non-postoperative intra-abdominal infections?Targeted versus universal antifungal prophylaxis among liver transplant recipientsUpdate in sepsis and pulmonary infections 2013.Candida Surveillance in Surgical Intensive Care Unit (SICU) in a Tertiary Institution.Antifungal de-escalation was not associated with adverse outcome in critically ill patients treated for invasive candidiasis: post hoc analyses of the AmarCAND2 study data.Epidemiology of invasive candidiasis in a surgical intensive care unit: an observational study.Intra-Abdominal Candidiasis: The Importance of Early Source Control and Antifungal TreatmentA randomized, placebo-controlled trial of preemptive antifungal therapy for the prevention of invasive candidiasis following gastrointestinal surgery for intra-abdominal infections.Antifungal activity of the piroctone olamine in experimental intra-abdominal candidiasis.Contribution of Candida biomarkers and DNA detection for the diagnosis of invasive candidiasis in ICU patients with severe abdominal conditionsProspective Evaluation of Serum β-Glucan Testing in Patients With Probable or Proven Fungal Diseases.Immunochip SNP array identifies novel genetic variants conferring susceptibility to candidaemia.Appropriate Treatment of Invasive Candidiasis in ICU: Timing, Colonization Index, Candida Score & Biomarkers, Towards de-Escalation?The promise of immunogenomics at the bedside: genetic risk of intra-abdominal candidiasis*.Factors predicting prolonged empirical antifungal treatment in critically ill patients.What's new in the clinical and diagnostic management of invasive candidiasis in critically ill patients.Non-cultural methods for the diagnosis of invasive fungal disease.Conclusion and future perspectives on antifungal stewardship.Diagnostic of Fungal Infections Related to Biofilms.Use of Fungal Diagnostics and Therapy in Pediatric Cancer Patients in Resource-Limited Settings.The current treatment landscape: candidiasis.Serum 1,3-beta-d-glucan for antifungal treatment stratification at the intensive care unit and the influence of surgery.(1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: an observational study.Discontinuation of empirical antifungal therapy in ICU patients using 1,3-β-d-glucan.Evaluation of the (1,3)-β-D-glucan assay for the diagnosis of neonatal invasive yeast infections.Association between source control and mortality in 258 patients with intra-abdominal candidiasis: a retrospective multi-centric analysis comparing intensive care versus surgical wards in Spain.
P2860
Q22305429-0A423980-14B8-4746-AB74-1C4EED836A5DQ26745677-A66CF878-A80C-4BDB-95BF-2F9DFFBEFEF6Q26852351-1DEA0981-CAF4-4C6A-A84A-F7046EAA6F57Q27012454-0FF9C9FE-9683-44B2-A34C-F329178C3713Q30235457-2E0949C0-7D6D-4446-8DE2-17C1D5071789Q30251428-83D47384-B820-43CE-8F8B-A8A1943B892FQ30397906-B45D35FB-391A-4856-83FE-F348E895A56EQ33736888-4BF8F00A-ACBA-439B-A683-0F733B5D92EEQ33833262-10D49522-B741-4FFB-AC5A-84A85E69F159Q34452343-0433F266-1D55-4B15-8F25-A354B389DFECQ34487220-15FBF973-3A65-45B6-82CD-C330295A1C3FQ34505582-78E85BB3-D147-46CB-BDDD-CBFA6BB4EDFDQ34528342-A5E17610-3BD8-4C2B-B09C-0721241EE9B5Q35122093-E5B0C7E8-354F-4CD1-943F-3B3AF2E454DAQ35149444-D0C90C44-C979-4513-8886-5EBA21719C43Q35194743-D6138559-D25D-4094-AE3E-692FEAF13407Q35199001-9089FACE-4EA5-4189-AFE2-4B0F466F9011Q35681680-F888A75D-126C-4B50-A034-D8B6FE86CAA6Q35775400-3795F7B0-B9EE-4515-83AC-1FAD544B1523Q35790746-C13218B3-5D88-4EF8-9DF9-0A372721F687Q36001726-FDEC3C99-AE6F-4077-84CF-E83504796A35Q36276211-ED2CD303-C232-4E6B-B806-4BE5CB7619C3Q36804115-D058E77F-2AEB-4BC0-A4D4-FFBBE37B2058Q36902916-6337EAC7-ACDF-4F66-B282-72554CC1DCB6Q37089475-1CF3A386-BBE5-44C4-A939-0A4083F1BBFEQ37481373-6D29898C-F6AE-4135-B2C5-635F654F6D87Q37551817-F61DA375-2874-4512-AD7C-72FE9C93A80DQ37673081-7D8419C7-51CF-43EE-813C-A44C3112CAC5Q37699716-DC6F0BED-911F-411B-A865-5794A2AC61D8Q38203447-36D69944-5A80-4B45-9E17-58772182DA41Q38266817-67C022BE-1299-4FF6-A157-133879E4F101Q38791567-7508EA39-7053-4651-AFBD-B061563BEAFCQ38853348-17BF5550-E67D-443A-9535-7EBEF9F51195Q38965488-116E7660-D79C-4283-A09F-14CA06FF5740Q39018200-06C26365-EA0B-4C51-AC54-79B6DF56D963Q39367519-F4981C1A-6EC3-48E4-95D0-F6049184B6FAQ39812922-AA39BF78-80D8-48D4-ACE7-52622EE8786CQ40101829-246B28D0-759F-4405-90F5-0036002D57ECQ40266645-CF5A40AC-C765-45DF-8412-66DD3E555096Q40533714-2573FA0F-663D-4A11-834E-19001D00F089
P2860
β-glucan antigenemia anticipates diagnosis of blood culture-negative intraabdominal candidiasis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
β-glucan antigenemia anticipat ...... ve intraabdominal candidiasis.
@en
β-glucan antigenemia anticipat ...... ve intraabdominal candidiasis.
@nl
type
label
β-glucan antigenemia anticipat ...... ve intraabdominal candidiasis.
@en
β-glucan antigenemia anticipat ...... ve intraabdominal candidiasis.
@nl
prefLabel
β-glucan antigenemia anticipat ...... ve intraabdominal candidiasis.
@en
β-glucan antigenemia anticipat ...... ve intraabdominal candidiasis.
@nl
P2093
P2860
P50
P1476
β-glucan antigenemia anticipat ...... ve intraabdominal candidiasis.
@en
P2093
Christina Orasch
Frederic Tissot
Fungal Infection Network of Switzerland (FUNGINOS)
Jacques Bille
Martin Siegemund
Oscar Marchetti
Philippe Eggimann
Stefan Zimmerli
Ursula Flückiger
P2860
P304
P356
10.1164/RCCM.201211-2069OC
P407
P577
2013-11-01T00:00:00Z